This is not the most recent version of the article. View current version (6 MAR 2015)

Intervention Review

Perphenazine for schizophrenia

  1. Benno Hartung1,*,
  2. Makoto Wada2,
  3. Gerd Laux3,
  4. Stefan Leucht4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 24 JAN 2005

Assessed as up-to-date: 21 OCT 2004

DOI: 10.1002/14651858.CD003443.pub2


How to Cite

Hartung B, Wada M, Laux G, Leucht S. Perphenazine for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003443. DOI: 10.1002/14651858.CD003443.pub2.

Author Information

  1. 1

    Heinrich-Heine-Universitaet Duesseldorf, Institut fuer Rechtsmedizin, Dusselfdorf, Germany

  2. 2

    Kyoto University, Department of Psychiatry, Kyoto, Japan

  3. 3

    Bezirkskrankenhaus Gabersee, Wasserburg, Bavaria, Germany

  4. 4

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

*Benno Hartung, Institut fuer Rechtsmedizin, Heinrich-Heine-Universitaet Duesseldorf, Moorenstr. 5, Dusselfdorf, 40225, Germany. benno.hartung@gmx.de. Benno.Hartung@med.uni-duesseldorf.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2005

SEARCH

This is not the most recent version of the article. View current version (06 MAR 2015)

  1. You have free access to this content

    Current Version

    Perphenazine for schizophrenia

    Benno Hartung, Stephanie Sampson and Stefan Leucht

    Version of Record online: 6 MAR 2015 | DOI: 10.1002/14651858.CD003443.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Perphenazine for schizophrenia

    Benno Hartung, Makoto Wada, Gerd Laux and Stefan Leucht

    Version of Record online: 24 JAN 2005 | DOI: 10.1002/14651858.CD003443.pub2

  2. Version 1

    Perphenazine for schizophrenia

    S Leucht and B Hartung

    Version of Record online: 23 OCT 2001 | DOI: 10.1002/14651858.CD003443